Biblioteca Virtuale per la Salute – Piemonte – "Le biblioteche non si fanno…crescono" A. Birrell

Sfoglia per AUTORE
DI MAIO M
Collezione AOU San Luigi di Orbassano

Items : 108

Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2024 Oct;22(5):102138. doi: 10.1016/j.clgc.2024.102138. Epub 2024 Jun 12.

2024
ASL Asti
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Tucci M; Scagliotti GV; Di Maio M; Palesandro E; Poletto S; Calabrese M; Saporita I; Crespi V; Farinea G; Di Stefano RF; Gallina A; Fossati N; Zilli T; Delcuratolo MD; Gillessen S; Turco F; Vogl UM; Buttigliero C;

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13

2024
AOU Città della Salute di Torino
ASL Torino 4
AOU San Luigi di Orbassano

Di Maio M; Novello S; Sperone P; Vellani G; Vignani F; Dionisio R; Paratore C; Valsecchi AA; Ferrari G;

Meta-Analysis on the Combination of Chemotherapy With Programmed Death-Ligand 1 and Programmed Cell Death Protein 1 Blockade as First-Line Treatment for Unresectable Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2024 Jan;19(1):166-172. doi: 10.1016/j.jtho.2023.08.004. Epub 2023 Aug 9.

2024
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Remon J; Bironzo P; Genova C; Facchinetti F; Aldea M; Le Péchoux C; Novello S; Barlesi F; Besse B; Planchard D; Tagliamento M;

Real-world retrospective study of KRAS mutations in advanced non-small cell lung cancer in the era of immunotherapy. in Cancer / Cancer. 2023 Jun 1;129(11):1662-1671. doi: 10.1002/cncr.34731. Epub 2023 Mar 11.

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Bironzo P; Scagliotti GV; Righi L; Novello S; Di Maio M; Passiglia F; Listì A; Napoli VM; Jacobs F; Cani M;

Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients-An Italian Single-Center Experience. in Biomedicines / Biomedicines. 2023 Jan 9;11(1):165. doi: 10.3390/biomedicines11010165.

2023
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Passiglia F; Scagliotti GV; D'Amiano C; Gianetta M; Di Maio M; Capelletto E; Bianco V; Napoli VM; Leone G; Turco F; Audisio A; Cecchi C; Delcuratolo MD; Cetoretta V; Parlagreco E; Pisano C; Garbo E; Ferrari G; Bironzo P; Persano I; Del Rio B; Cani M; Bertaglia V;

Therapeutic sequencing in advanced renal cell carcinoma: How to choose considering clinical and biological factors. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2023 Jan;181:103881. doi: 10.1016/j.critrevonc.2022.103881. Epub 2022 Nov 24

2023
AO Ordine Mauriziano
ASL Asti
AOU San Luigi di Orbassano

Scagliotti GV; Buttigliero C; Di Maio M; Audisio A; Brusa F; Ungaro A; Audisio M; Samuelly A; Turco F; Di Stefano RF; Tucci M; Delcuratolo MD;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
AO Cuneo
ASL Cuneo 2
AO Ordine Mauriziano
ASL Torino 4
AOU San Luigi di Orbassano

Tuninetti V; Turco F; Fabi A; Perrone F; Di Maio M; Reale ML; Trastu F; Paratore C; Marandino L; Mariniello A; Lombardi P; Ghisoni E; Bungaro M; Caglio A; Di Liello R; Gamba T; Gargiulo P; Rossi A; Aimar G; Audisio M;

Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis. in Tumori / Tumori. 2023 Apr;109(2):233-243. doi: 10.1177/03008916221077144. Epub 2022 Mar 31.

2023
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Ungaro A; Parlagreco E; Audisio A; Audisio M; Angusti T; Parente A; Di Stefano RF; Urban S; Pisano C; Samuelly A; Tucci M; Turco F;

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. in Cells / Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Geuna M; Bironzo P; Passiglia F; Righi L; Sangiolo D; Novello S; Paratore C; Di Maio M; De Filippis M; Bungaro M; Bertaglia V; Mecca C; Consito L; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A;

Detection of ALK fusion variants by RNA-based NGS and clinical outcome correlation in NSCLC patients treated with ALK-TKI sequences. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2022 Oct;174:200-211. doi: 10.1016/j.ejca.2022.07.026. Epub 2022 Aug 28.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Righi L; Novello S; Graziano P; Scagliotti GV; Bria E; Volante M; Rossi A; Rossi G; Osman G; Di Maio M; Bareggi C; Del Conte A; Cappuzzo F; Cortinovis D; Pilotto S; Gregorc V; Sergi C; Ghilardi L; Scotti V; Martelli O; Tiseo M; Galetta D; Maiello E; Rigutto A; Castellana S; Trombetta D; Gobbini E; Tabbò F; Muscarella LA; et alii...

Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial. in International journal of cancer / Int J Cancer. 2022 Nov 15;151(10):1760-1769. doi: 10.1002/ijc.34156. Epub 2022 Jun 23.

2022
ASL Torino 4
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Morano F; Pietrantonio F; Di Maio M; Di Bartolomeo M; Antonuzzo L; Giordano M; Rossi A; Ratti M; Petrelli F; Berenato R; Clavarezza M; Zaniboni A; Fanchini L; Murialdo R; Sartore-Bianchi A; Tampellini M; Bozzarelli S; Antoniotti C; Lonardi S; Pagani F; Prisciandaro M; Randon G; Raimondi A;

New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Jun;174:103682. doi: 10.1016/j.critrevonc.2022.103682. Epub 2022 Apr 11

2022
ASL Asti
ASL Torino 4
ASL Cuneo 1
ASL Cuneo 2
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Scagliotti GV; Di Maio M; Ortega C; Di Prima L; Audisio A; Turco F; Ungaro A; Parlagreco E; Di Stefano RF; Audisio M; Tucci M;

High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status. in Journal of hematology & oncology / J Hematol Oncol. 2022 Jan 21;15(1):9. doi: 10.1186/s13045-022-01226-2.

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Pinato DJ; Russo A; Russano M; Porzio G; Tiseo M; Ficorella C; Addeo A; Banna GL; Friedlaender A; Metro G; Spinelli GP; Passiglia F; Migliorino MR; Ricciardi S; Pecci F; Zoratto F; De Tursi M; Di Marino P; Mansueto G; Tuzi A; Gori S; Della Gravara L; Rastelli F; Chiari R; Macerelli M; Marchetti P; Gelibter A; Antonuzzo L; Berardi R; et alii...

Cabozantinib beyond progression improves survival in advanced renal cell carcinoma patients: the CABEYOND study (Meet-URO 21). in Expert review of anticancer therapy / Expert Rev Anticancer Ther. 2022 Jan;22(1):115-121. doi: 10.1080/14737140.2022.2002688. Epub 2021 No

2022
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pignata S; De Braud FG; Verzoni E; Procopio G; Ottini A; Guadalupi V; Claps M; Sepe P; Buttigliero C; Stellato M; Roviello G; Di Lorenzo G; Mucciarini C; Messina C; Santini D; Casadei C; Sorarù M; Buti S; De Giorgi U; Bimbatti D; Di Maio M; Zattarin E; Mennitto A;

Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside. in Cells / Cells. 2022 Feb 25;11(5):803. doi: 10.3390/cells11050803.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Delcuratolo MD; Ungaro A; Buttigliero C; Di Maio M; Audisio A; Di Prima L; Turco F; Scagliotti GV; Pisano C; Tucci M;

Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors. in JAMA network open / JAMA Netw Open. 2022 Feb 1;5(2):e220290. doi: 10.1001/jamanetworkopen.2022.0290.

2022
ASL Torino 4
ASL Città di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Spada F; Andreasi V; Di Bartolomeo M; Casadei R; Coppa J; Milione M; Sabella G; Modica R; Scalorbi F; Falconi M; Severi S; Zanata I; Bracigliano A; Puliafito I; Ambrosio MR; Lamberti G; Cingarlini S; Rinzivillo M; Pignata SA; Rocca PA; Persano I; Versari A; Bongiovanni A; Seregni E; Maccauro M; Lastoria S; Di Maio M; Porcu L; Giacomelli L; et alii...

Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study. in Minerva urology and nephrology / Minerva Urol Nephrol. 2022 Dec;74(6):703-713. doi: 10.23736/S2724-6051.22.04701-2. Epub 2022 Feb 11.

2022
ASL Asti
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Pisano C; DI Maio M; Tucci M; Scagliotti GV; Samuelly A; DI Stefano RF; Turco F; Bungaro M; Parente A; Buttigliero C; Angusti T;

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020. in ESMO open / ESMO Open. 2022 Dec;7(6):100593. doi: 10.1016/j.esmoop.2022.100593. Epub 2022 Oct 12.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Mariniello A; Perrone F; Reale ML; Gargiulo P; Di Liello R; Gamba T; Caglio A; Bungaro M; Audisio M; Paratore C; Zichi C;

Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy. in Cancer communications (London, England) / Cancer Commun (Lond). 2022 Aug;42(8):683-688. doi: 10.1002/cac2.12340. Epub 2022 Jul 22.

2022
ASL Asti
ASL Cuneo 2
ASL Torino 4
ASL Cuneo 1
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Ungaro A; Audisio M; Scagliotti GV; Di Maio M; Delcuratolo MD; Audisio A; Ortega C; Pisano C; Buttigliero C; Di Stefano RF; Tucci M;

A systematic review and meta-analysis of trials assessing PD-1/PD-L1 immune checkpoint inhibitors activity in pre-treated advanced stage malignant mesothelioma. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2022 Apr;172:103639. doi: 10.1016/j.critrevonc.2022.103639. Epub 2022 Feb 19

2022
ASL Asti
AOU Città della Salute di Torino
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Scagliotti GV; Carnio S; Buffoni L; Passiglia F; Zichi C; Capelletto E; Reale ML; Artusio E; Olmetto E; Bertaglia V; Paratore C; Bungaro M; Curcio H; De Luca E; Tagliamento M; Audisio M; Rapetti SG; Bironzo P; Pignataro D; Di Maio M;

Impact of age and gender on the efficacy and safety of upfront therapy with panitumumab plus FOLFOX followed by panitumumab-based maintenance: a pre-specified subgroup analysis of the Valentino study. in ESMO open / ESMO Open. 2021 Oct;6(5):100246. doi: 10.1016/j.esmoop.2021.100246. Epub 2021 Aug 17.

2021
AOU Città della Salute di Torino
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Pietrantonio F; Di Bartolomeo M; Corallo S; Morano F; Ratti M; Berenato R; Zaniboni A; Clavarezza M; Murialdo R; Ritorto G; Tampellini M; Amatu A; Smiroldo V; Antoniotti C; Lonardi S; Leone AG; Raimondi A; Fucà G;

Clinical and Molecular Features of Epidermal Growth Factor Receptor (EGFR) Mutation Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated with Tyrosine Kinase Inhibitors (TKIs): Predictive and Prognostic Role of Co-Mutations. in Cancers / Cancers (Basel). 2021 May 17;13(10):2425. doi: 10.3390/cancers13102425.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Scagliotti GV; Bussolino F; Righi L; Di Maio M; Passiglia F; Caglio A; Listì A; Sperone T; Tabbò F; Reale ML; Bironzo P; Novello S;

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;

Post-progression outcomes of NSCLC patients with PD-L1 expression ? 50% receiving first-line single-agent pembrolizumab in a large multicentre real-world study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;148:24-35. doi: 10.1016/j.ejca.2021.02.005. Epub 2021 Mar 12.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano
AOU Novara

Russo A; Adamo V; Metro G; De Filippis M; Simona C; Natalizio S; Migliorino MR; Ricciardi S; Landi L; Minuti G; Buti S; Nigro O; Cantini L; Russano M; Citarella F; Bracarda S; Filetti M; Zoratto F; Mansueto G; De Tursi M; Gori S; Rocco D; Chiari R; Rastelli F; Gelibter A; Targato G; Signorelli D; De Toma A; Mazzoni F; et alii...

Synaptophysin expression in (V600EBRAF-)mutated advanced colorectal cancers identifies a new subgroup of tumours with worse prognosis. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Mar;146:145-154. doi: 10.1016/j.ejca.2021.01.016. Epub 2021 Feb 16.

2021
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Dei Tos AP; Lonardi S; Zagonel V; Borga C; Biason P; Centonze G; Santini D; Salmaso R; Aprile G; Salvatore L; Calvetti L; Smiroldo V; Rimassa L; De Maglio G; Cortiula F; Morano F; Volante M; Boccaccino A; Bergamo F; Zichi C; Sperti E; Dell'Aquila E; Pella N; Pietrantonio F; Schirripa M; Cremolini C; Maddalena G; Milione M; Fassan M; et alii...

Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC. in Endocrine-related cancer / Endocr Relat Cancer. 2021 Jun 2;28(7):R207-R216. doi: 10.1530/ERC-20-0457.

2021
ASL Asti
ASL Vercelli
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Buttigliero C; Di Maio M; Scagliotti GV; Pisano C; Audisio M; Samuelly A; Bungaro M; Tucci M; Di Stefano RF; Turco F;

Predictive ability of a drug-based score in patients with advanced non-small-cell lung cancer receiving first-line immunotherapy. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 Jun;150:224-231. doi: 10.1016/j.ejca.2021.03.041. Epub 2021 May 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Novara

Cannita K; Porzio G; Friedlaender A; Addeo A; Banna GL; Spinelli GP; Russo A; Adamo V; Metro G; Olmetto E; Tabbò F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Tuzi A; Bisonni R; Follador A; Siringo M; Gelibter A; Signorelli D; De Toma A; Garassino MC; Mazzoni F; Russano M; Citarella F; Filetti M; Zoratto F; Mansueto G; et alii...

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2021 Jan;157:103185. doi: 10.1016/j.critrevonc.2020.103185. Epub 2020 Nov 27

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Buttigliero C; Di Maio M; Scagliotti GV; Di Stefano RF; Turco F; Tucci M; Pisano C;

Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. in Minerva urology and nephrology / Minerva Urol Nephrol. 2021 Dec;73(6):803-814. doi: 10.23736/S2724-6051.21.04186-2. Epub 2021 Mar 29.

2021
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
ASL Torino 4
AO Ordine Mauriziano

Buttigliero C; DI Maio M; Scagliotti GV; Tarenghi F; Vignani F; Bungaro M; Samuelly A; Turco F; DI Stefano RF; Tucci M; Pisano C;

Descriptive Comparative Analysis of Patients With Cancer Referring to the Emergency Department of an Italian University Hospital Across the Severe Acute Respiratory Syndrome Coronavirus 2 Waves. in JCO oncology practice / JCO Oncol Pract. 2021 Dec;17(12):e1887-e1894. doi: 10.1200/OP.21.00098. Epub 2021 Jul 6.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Passiglia F; Capelletto E; Boccuzzi A; Caramello V; Olmetto E; Persano I; De Filippis M; Pisano C; Bironzo P; Mariniello A; Di Maio M; Novello S;

Differential influence of antibiotic therapy and other medications on oncological outcomes of patients with non-small cell lung cancer treated with first-line pembrolizumab versus cytotoxic chemotherapy. in Journal for immunotherapy of cancer / J Immunother Cancer. 2021 Apr;9(4):e002421. doi: 10.1136/jitc-2021-002421.

2021
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino
AOU Novara

Russo A; Adamo V; Metro G; Bironzo P; Passiglia F; Migliorino MR; Ricciardi S; Landi L; Minuti G; Bordi P; Tuzi A; Cantini L; Russano M; Citarella F; Santini D; Filetti M; Zoratto F; Mansueto G; Di Marino P; Grassadonia A; Michele T; Inno A; Della Gravara L; Rocco D; Chiari R; Rastelli F; Macerelli M; Marchetti P; Siringo M; et alii...

Cabozantinib (Cabo) beyond progression improves survival in advanced renal cell carcinoma patients: The CABEYOND study (Meet-Uro 21) in Journal of Clinical Oncology

2021
AOU San Luigi di Orbassano

Procopio G; Mennitto A; Di Maio M; Zattarin E; Maruzzo M; De Giorgi U; Santini D; Buti S; Casadei C; Soraru M; Di Lorenzo G; Messina C; Mucciarini C; Roviello G; Buttigliero C; Stellato M; Sepe P; Pignata S; De Braud FG; Verzoni E;

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review. in Cancers / Cancers (Basel). 2020 Sep 9;12(9):2568. doi: 10.3390/cancers12092568.

2020
ASL Asti
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Vercelli

Tucci M; Di Maio M; Necchi A; Gamba T; Buttigliero C; Vignani F; Marandino L;

First-line pembrolizumab in advanced non-small cell lung cancer patients with poor performance status. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 May;130:155-167. doi: 10.1016/j.ejca.2020.02.023. Epub 2020 Mar 25.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
ASL Città di Torino

Banna GL; Camisa R; Di Maio M; Rossi G; Rossi A; Cortinovis DL; Bria E; Novello S; Baldessari C; Bartoli G; Pizzutilo EG; Landi L; Toschi L; Dall'Olio FG; Sartori G; Ciccone LP; Garassino MC; Guaitoli G; Zanelli F; De Carlo E; Camerini A; Bearz A; Sala E; Cerea G; Migliorino MR; Bennati C; Ardizzoni A; Vita E; Rossi S; et alii...

Real-world outcomes according to treatment strategies in ALK-rearranged non-small-cell lung cancer (NSCLC) patients: an Italian retrospective study. in Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico / Clin Transl Oncol. 2020 Mar;22(3):294-301. doi: 10.1007/s12094-019-02222-8. Epub 2019 Oct 19.

2020
AOU San Luigi di Orbassano
ASL Città di Torino
AO Ordine Mauriziano

Novello S; Tiseo M; Di Maio M; Galetta D; Bria E; Rossi G; Cortinovis D; Rizzo P; Tabbò F; Delmonte A; Bareggi C; Sergi C; Del Conte A; Graziano P; Gregorc V; Casartelli C; Rossi A; Borra G; Maiello E; Martelli O; Scotti V; Riccardi F; Cecere F; Cappuzzo F; Pilotto S; Osman G; Ghilardi L; Pizzutillo P; Bordi P; et alii...

Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature. in Acta oncologica (Stockholm, Sweden) / Acta Oncol. 2020 Mar;59(3):315-319. doi: 10.1080/0284186X.2019.1672891. Epub 2019 Oct 4.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Atzeni F; Di Maio M; Scagliotti GV; Muratori L; Parisi F; Brizzi MP; Trevisi E; La Salvia A;

Neuroendocrine breast carcinoma: a rare but challenging entity. in Medical oncology (Northwood, London, England) / Med Oncol. 2020 Jul 25;37(8):70. doi: 10.1007/s12032-020-01396-4.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; De Rosa G; Scagliotti GV; Brizzi MP; La Salvia A; Daniele L; Trevisi E;

Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2020 Jan;139:47-54. doi: 10.1016/j.lungcan.2019.10.022. Epub 2019 Oct 31.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Maio M; Perrone F; Novello S; Scagliotti GV; Aglietta M; Bironzo P; Sonetto C; La Salvia A; Muratori L; Trevisi E; Leone G; Mariniello A; Di Stefano RF; Pignataro D; Ghisoni E; Zichi C; Marandino L; Lombardi P; De Luca E; Reale ML;

Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Feb;146:102877. doi: 10.1016/j.critrevonc.2020.102877. Epub 2020 Jan 18

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Scagliotti GV; Aglietta M; Novello S; Leone F; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; De Luca E; Zichi C; Marandino L; Lombardi P; Di Maio M;

Impact of adoption of patient-reported outcomes in clinical practice on the accuracy of symptom reporting in medical records of cancer patients. in Recenti progressi in medicina / Recenti Prog Med. 2020 Dec;111(12):740-748. doi: 10.1701/3509.34965.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Zilio E; Pozzi D; Polimeno L; Ciriolo G; Comite R; Codegone F; Florio S; Fusco L; Audisio M; Ballaminut D; Bellezza A; Chiotto P; Zichi C; De Luca E; Vignani F; Sperti E; Guida G; Turco CGC; Lacidogna G; Baratelli C; Marino D; Terzolo S; Di Maio M;

Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2020 Dec;72(6):737-745. doi: 10.23736/S0393-2249.20.03708-X. Epub 2020 Apr 10.

2020
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Numico G; Scagliotti GV; Guglielmini P; Lacidogna G; Turco F; Di Stefano RF; Pisano C; Buttigliero C; Tucci M; Sonetto C; Vignani F;

Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2020 Aug;152:102994. doi: 10.1016/j.critrevonc.2020.102994. Epub 2020 May 24

2020
ASL Asti
AOU San Luigi di Orbassano
ASL Vercelli
AO Ordine Mauriziano

Di Maio M; Tucci M; Scagliotti GV; Vignani F; Turco F; Tabbò F; Pisano C; Di Stefano RF; Buttigliero C; Leone G;

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with panitumumab-based first-line treatment strategy: A pre-specified secondary analysis of the Valentino study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2020 Aug;135:230-239. doi: 10.1016/j.ejca.2020.04.048. Epub 2020 Jul 2.

2020
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Pietrantonio F; Di Bartolomeo M; Peverelli G; de Braud F; Antista M; Niger M; Bergamo F; Cinieri S; Longarini R; Giordano M; Antonuzzo L; Petrelli F; Adamo V; Tomasello G; Zaniboni A; Clavarezza M; Murialdo R; Tampellini M; Ritorto G; Sartore-Bianchi A; Rimassa L; Antoniotti C; Corallo S; Lonardi S; Morano F; Raimondi A; Di Maio M;

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG. in Therapeutic advances in medical oncology / Ther Adv Med Oncol. 2020 Nov 2;12:1758835920968463. doi: 10.1177/1758835920968463. eCollection 2020.

2020
ASL Cuneo 2
AOU San Luigi di Orbassano
ASL Città di Torino
ASL VCO
AO Ordine Mauriziano
AOU Alessandria

Buti S; Tognetto M; Vaccaro V; Di Costanzo F; Maiello E; Labianca R; Pinto C; Garzoli E; Pilotto S; Castro A; Carrozza F; Gori S; Verusio C; Atzori F; Dicorato AM; Giordano P; Corbo C; Gernone A; Prati V; Carnio S; Tassinari D; Cavanna L; Meriggi F; Longo L; Sartori D; Iannopollo M; Pezzuolo D; Bracarda S; Bonetti A; et alii...

Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018. in Clinical genitourinary cancer / Clin Genitourin Cancer. 2019 Oct;17(5):332-347.e2. doi: 10.1016/j.clgc.2019.07.007. Epub 2019 Jul 20

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Novello S; Aglietta M; Tucci M; Buttigliero C; Sonetto C; La Salvia A; Muratori L; Leone G; Trevisi E; Mariniello A; Ghisoni E; Di Stefano RF; Pignataro D; Reale ML; Lombardi P; Zichi C; De Luca E; Marandino L; Scagliotti GV; Perrone F; Di Maio M;

Women With Synchronous or Metachronous Lung and Ovarian Cancer: A Multi-Institutional Report. in In vivo (Athens, Greece) / In Vivo. 2019 Nov-Dec;33(6):2021-2026. doi: 10.21873/invivo.11699.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Valabrega G; DI Maio M; Zichi C; Giajlevra M; Parra HS; Gelibter A; Cecere F; Barbieri F; Del Conte A; Chiari R; Righi L; Catino A; Novello S; Ghisoni E; Mariniello A;

Long term control of luteinized thecoma with sclerosing peritonitis with leuprorelin and tamoxifen treatment. in Gynecologic oncology reports / Gynecol Oncol Rep. 2019 Feb 16;28:44-46. doi: 10.1016/j.gore.2019.02.004. eCollection 2019 May.

2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Scagliotti GV; Di Maio M; Andreozzi A; Sperone P; Gorzegno G; Muratori L;

Therapeutic options for first-line metastatic castration-resistant prostate cancer: Suggestions for clinical practise in the CHAARTED and LATITUDE era. in Cancer treatment reviews / Cancer Treat Rev. 2019 Mar;74:35-42. doi: 10.1016/j.ctrv.2019.01.002. Epub 2019 Jan 7.

2019
AOU San Luigi di Orbassano

Scagliotti GV; Veccia A; Rossetti S; Rizzo M; Maines F; Kinspergher S; Di Maio M; Cavaliere C; D'aniello C; Buttigliero C; Tucci M; Caffo O; Facchini G;

Systematic Review of adverse events reporting in clinical trials leading to approval of targeted therapy and immunotherapy. in Future oncology (London, England) / Future Oncol. 2019 Jul;15(21):2543-2553. doi: 10.2217/fon-2018-0772. Epub 2019 Jun 26.

2019
AOU San Luigi di Orbassano

Locati LD; Di Giannantonio V; Sbrana A; Musettini G; Sonetto C; Bironzo P; Botta L; Bossi P; Di Maio M; Antonuzzo A;

Target therapies in recurrent or metastatic head and neck cancer: state of the art and novel perspectives. A systematic review. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2019 Jul;139:41-52. doi: 10.1016/j.critrevonc.2019.05.002. Epub 2019 May 3.

2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Sperone P; La Salvia A; Muratori L;

The role of patient-reported outcomes in outpatients receiving active anti-cancer treatment: impact on patients' quality of life. in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer / Support Care Cancer. 2019 Dec;27(12):4697-4704. doi: 10.1007/s00520-019-04777-2. Epub 2019 Apr 4.

2019
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Terzolo S; Zilio E; Pozzi D; Polimeno L; Fusco L; Florio S; Comite R; Codegone F; Ciriolo G; Chiotto P; Bellezza A; Audisio M; Ballaminut D; De Luca E; Marino D; Zichi C; Vignani F; Sperti E; Lacidogna G; Turco CGC; Baratelli C;

Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Papotti M; Di Maio M; Novello S; Righi L; Bussolino F; Ruffini E; Ardissone F; Comunanza V; Passone E; Cartia CF; Tabbò F; Bironzo P; Milosevic V; Ananthanarayanan P; Gagliasso M; Costardi L; Maletta F; Pradotto M; Salaroglio IC; Kopecka J; Napoli F; Scagliotti GV; Riganti C;

Capecitabine plus temozolomide in well- or moderately-differentiated primary atypical neuroendocrine tumours - single-centre experience of two cases. in Endokrynologia Polska / Endokrynol Pol. 2019;70(4):380-383. doi: 10.5603/EP.a2018.0076. Epub 2018 Oct 25.

2019
AOU San Luigi di Orbassano

Di Maio M; Trevisi E; Muratori L; Brizzi MP; La Salvia A; Scagliotti GV;

Quality-of-life (QoL) assessment and reporting in prostate cancer: A systematic review of phase III trials published between 2012 and 2016 in Journal of Clinical Oncology

2019
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; ButtIgliero C; Tucci M; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences. in Cancer treatment reviews / Cancer Treat Rev. 2018 Sep;69:215-223. doi: 10.1016/j.ctrv.2018.07.010. Epub 2018 Jul 20.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Scagliotti GV; Ricardi U; Ruo Redda MG; Di Stefano RF; Leone G; Zichi C; Tucci M; Allis S; Buttigliero C; Filippi AR;

Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Sep;129:124-132. doi: 10.1016/j.critrevonc.2018.07.004. Epub 2018 Jul 1

2018
AOU San Luigi di Orbassano

Di Nunno V; De Luca E; Buttigliero C; Tucci M; Vignani F; Gatto L; Zichi C; Ardizzoni A; Di Maio M; Massari F;

A review of guidelines for lung cancer. in Journal of thoracic disease / J Thorac Dis. 2018 May;10(Suppl 13):S1556-S1563. doi: 10.21037/jtd.2018.03.54.

2018
AOU San Luigi di Orbassano

Bironzo P; Di Maio M;

Thymidine phosphorylase: the unforeseen driver in colorectal cancer treatment? in Future oncology (London, England) / Future Oncol. 2018 May;14(12):1223-1231. doi: 10.2217/fon-2017-0627. Epub 2018 Apr 27.

2018
AOU San Luigi di Orbassano

Tampellini M; Bironzo P; Di Maio M; Scagliotti GV;

Effect of Contract Research Organization Bureaucracy in Clinical Trial Management: A Model From Lung Cancer. in Clinical lung cancer / Clin Lung Cancer. 2018 Mar;19(2):191-198. doi: 10.1016/j.cllc.2017.10.012. Epub 2017 Oct 28.

2018
AOU San Luigi di Orbassano

Gobbini E; Pilotto S; Pasello G; Polo V; Di Maio M; Arizio F; Galetta D; Petrillo P; Chiari R; Matocci R; Di Costanzo A; Di Stefano TS; Aglietta M; Cagnazzo C; Sperduti I; Bria E; Novello S;

Loss of C/EBP-? LIP drives cisplatin resistance in malignant pleural mesothelioma. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2018 Jun;120:34-45. doi: 10.1016/j.lungcan.2018.03.022. Epub 2018 Mar 26.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Rubinstein M; Novello S; Di Maio M; Napoli F; Pradotto M; Capelletto E; Ricci L; Ananthanarayanan P; Milosevic V; Grosso F; Libener R; Orecchia S; Salaroglio IC; Righi L; Kopecka J; Scagliotti GV; Riganti C;

A systematic review of the safety profile of the different combinations of fluoropyrimidines and oxaliplatin in the treatment of colorectal cancer patients. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Feb;122:21-29. doi: 10.1016/j.critrevonc.2017.12.010. Epub 2017 Dec 16.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Baratelli C; Zichi C; Di Maio M; Brizzi MP; Sonetto C; Scagliotti GV; Tampellini M;

Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2018 Dec 1;29(12):2288-2295. doi: 10.1093/annonc/mdy449.

2018
AOU San Luigi di Orbassano

Marandino L; La Salvia A; Sonetto C; De Luca E; Pignataro D; Zichi C; Di Stefano RF; Ghisoni E; Lombardi P; Mariniello A; Reale ML; Trevisi E; Leone G; Muratori L; Marcato M; Bironzo P; Novello S; Aglietta M; Scagliotti GV; Perrone F; Di Maio M;

Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. in Gastroenterology / Gastroenterology. 2018 Aug;155(2):479-489.e7. doi: 10.1053/j.gastro.2018.04.010. Epub 2018 Apr 13.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AO Cuneo

Mazzaferro V; Delle Fave G; Buzzoni R; Giacomelli L; Milione M; Lo Russo G; Prinzi N; Concas L; Femia D; Tafuto S; Garattini SK; Di Costanzo F; Torniai M; Bajetta E; Ortolani S; Zaniboni A; Puliafito I; Panzuto F; Brighi N; Colao A; La Salvia A; Bongiovanni A; Ricci S; Fazio N; Cavalcoli F; Cauchi C; Duro M; Carnaghi C; Davì MV; et alii...

Efficacy of neurokinin-1 receptor antagonists in the prevention of chemotherapy-induced nausea and vomiting in patients receiving carboplatin-based chemotherapy: A systematic review and meta-analysis. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2018 Apr;124:21-28. doi: 10.1016/j.critrevonc.2018.02.001. Epub 2018 Feb 7.

2018
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Baratelli C; Bironzo P; Vignani F; Bria E; Sperti E; Marcato M; Roila F;

Hormonal treatment and quality of life of prostate cancer patients: new evidence. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2018 Apr;70(2):144-151. doi: 10.23736/S0393-2249.17.03066-1. Epub 2017 Dec 14.

2018
AOU San Luigi di Orbassano

Tucci M; Leone G; Buttigliero C; Zichi C; DI Stefano RF; Pignataro D; Vignani F; Scagliotti GV; DI Maio M;

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression. in International journal of clinical oncology / Int J Clin Oncol. 2018 Apr;23(2):281-286. doi: 10.1007/s10147-017-1195-x. Epub 2017 Sep 27.

2018
AOU San Luigi di Orbassano

Baratelli C; Tampellini M; Di Maio M; Ottone A; Brizzi MP; Forti L; Alabiso I; Sonetto C; Alabiso O; Scagliotti GV;

Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions. in OncoTargets and therapy / Onco Targets Ther. 2018 Oct 24;11:7353-7368. doi: 10.2147/OTT.S153764. eCollection 2018.

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Tucci M; Zichi C; Buttigliero C; Vignani F; Scagliotti GV; Di Maio M;

Biases in assessment and reporting of health-related quality of life (QoL): A systematic review of oncology randomized phase III trials published between 2012 and 2016 in Journal of Clinical Oncology

2018
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Molecular profiling in Italian patients with advanced non-small-cell lung cancer: An observational prospective study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2017 Sep;111:30-37. doi: 10.1016/j.lungcan.2017.06.009. Epub 2017 Jun 16.

2017
AOU San Luigi di Orbassano
AOU Città della Salute di Torino
AO Ordine Mauriziano

Novello S; Bordi P; Catino A; Pisconti S; Cortinovis D; Franchina T; Migliorino MR; Delmonte A; Buffoni L; Ceribelli A; Scotti V; Riccardi F; Gregorc V; Di Maio M; Rossi G; Bria E; Rossi A; Graziano P; Tiseo M; Galetta D; Gobbini E; Maiello E; Arizio F;

Chemotherapy and intercalated gefitinib or erlotinib in the treatment of advanced non-small-cell lung cancer. in Expert review of respiratory medicine / Expert Rev Respir Med. 2017 Mar;11(3):171-180. doi: 10.1080/17476348.2017.1290526. Epub 2017 Feb 9.

2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Rossi A; La Salvia A; Di Maio M;

Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. in Cancer treatment reviews / Cancer Treat Rev. 2017 Mar;54:1-9. doi: 10.1016/j.ctrv.2017.01.002. Epub 2017 Jan 11.

2017
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Vignani F; Scagliotti GV; Di Maio M;

Intercalated Chemotherapy and Epidermal Growth Factor Receptor Inhibitors for Patients With Advanced Non-Small-cell Lung Cancer: A Systematic Review and Meta-analysis. in Clinical lung cancer / Clin Lung Cancer. 2017 Jan;18(1):23-33.e1. doi: 10.1016/j.cllc.2016.08.006. Epub 2016 Oct 28.

2017
AOU San Luigi di Orbassano

La Salvia A; Rossi A; Galetta D; Gobbini E; De Luca E; Novello S; Di Maio M;

Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis. in Breast (Edinburgh, Scotland) / Breast. 2017 Feb;31:114-120. doi: 10.1016/j.breast.2016.10.021. Epub 2016 Nov 9.

2017
AOU San Luigi di Orbassano

Bonotto M; Gerratana L; Di Maio M; De Angelis C; Cinausero M; Moroso S; Milano M; Stanzione B; Gargiulo P; Iacono D; Minisini AM; Mansutti M; Fasola G; De Placido S; Arpino G; Puglisi F;

Negative hyper-selection of metastatic colorectal cancer patients for anti-EGFR monoclonal antibodies: the PRESSING case-control study. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2017 Dec 1;28(12):3009-3014. doi: 10.1093/annonc/mdx546.

2017
AOU San Luigi di Orbassano

Cremolini C; Morano F; Moretto R; Berenato R; Tamborini E; Perrone F; Rossini D; Gloghini A; Busico A; Zucchelli G; Baratelli C; Tamburini E; Tampellini M; Sensi E; Fucà G; Volpi C; Milione M; Di Maio M; Fontanini G; De Braud F; Falcone A; Pietrantonio F;

Can intercalating chemotherapy with epidermal growth factor receptor inhibitors delay development of treatment resistance in advanced non-small cell lung cancer? in Expert opinion on pharmacotherapy / Expert Opin Pharmacother. 2017 Dec;18(18):1899-1902. doi: 10.1080/14656566.2017.1409721. Epub 2017 N

2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano

La Salvia A; De Luca E; Rossi A; Di Maio M;

Treatment of Patients With Metastatic Colorectal Cancer in a Real-World Scenario: Probability of Receiving Second and Further Lines of Therapy and Description of Clinical Benefit. in Clinical colorectal cancer / Clin Colorectal Cancer. 2017 Dec;16(4):372-376. doi: 10.1016/j.clcc.2017.03.019. Epub 2017 Apr 8.

2017
AOU San Luigi di Orbassano

Tampellini M; Di Maio M; Baratelli C; Anania L; Brizzi MP; Sonetto C; La Salvia A; Scagliotti GV;

An exploratory analysis of the association between levels of hormones implied in steroid biosynthesis and activity of abiraterone in patients with metastatic castration-resistant prostate cancer. in Minerva urologica e nefrologica = The Italian journal of urology and nephrology / Minerva Urol Nefrol. 2017 Aug;69(4):349-358. doi: 10.23736/S0393-2249.16.02746-6. Epub 2016 Dec 22.

2017
AOU San Luigi di Orbassano

Bertaglia V; Tucci M; Vignani F; Buttigliero C; Aroasio E; Berruti A; Scagliotti GV; DI Maio M;

Zoledronic Acid Dosing Interval for Metastatic Cancer. in JAMA / JAMA. 2017 Apr 11;317(14):1477-1478. doi: 10.1001/jama.2017.2562.

2017
AOU San Luigi di Orbassano

Tucci M; Buttigliero C; Di Maio M;

Immediate or Delayed Nephrectomy in Patients With Metastatic Renal Cancer Who Are Receiving Targeted Agents: Is the Analysis at Risk for Guarantee-Time Bias? in Journal of clinical oncology : official journal of the American Society of Clinical Oncology / J Clin Oncol. 2017 Apr 10;35(11):1264. doi: 10.1200/JCO.2016.69.3580. Epub 2017 Feb 6.

2017
AOU San Luigi di Orbassano

Buttigliero C; Tucci M; Vignani F; Di Maio M;

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives. in BioMed research international / Biomed Res Int. 2017;2017:5618174. doi: 10.1155/2017/5618174. Epub 2017 Jun 7.

2017
AOU San Luigi di Orbassano
AO Ordine Mauriziano

Di Maio M; Scagliotti GV; Pignataro D; Vignani F; Buttigliero C; Leone G; Tucci M; Zichi C;

Dissecting primary resistance to anti-EGFRs in RAS and BRAF wt metastatic colorectal cancer (mCRC): A case-control study in Journal of Clinical Oncology

2017
AOU San Luigi di Orbassano

Cremolini C; Morano F; Moretto R; Berenato R; Tamborini E; Perrone F; Rossini D; Gloghini A; Busico A; Zucchelli G; Baratelli C; Tamburini E; Capone I; Volpi C; Milione M; Di Maio M; Fontanini G; De Braud FG; Falcone A; Pietrantonio F;

BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study. in Lung cancer (Amsterdam, Netherlands) / Lung Cancer. 2016 May;95:73-81. doi: 10.1016/j.lungcan.2016.02.011. Epub 2016 Feb 26.

2016
AOU San Luigi di Orbassano
AOU Alessandria

Rossi A; Spitaleri G; Bria E; Cecere F; Rijavec E; Rizzo E; Barbieri F; Menis J; Filipazzi V; Mucciarini C; Genestreti G; Bearz A; Barzelloni ML; Ardizzoia A; Banna GL; Casartelli C; Zilembo N; Cortinovis D; Piovano PL; Caffo O; Novello S; Martelli O; Di Maio M; Morabito A; Vavalà T; Follador A; Tiseo M; Galetta D;

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments. in Nature reviews. Clinical oncology / Nat Rev Clin Oncol. 2016 May;13(5):319-25. doi: 10.1038/nrclinonc.2015.222. Epub 2016 Jan 20.